Presentation Title

Breast Tissue Dielectric Constant (TDC) Assessed in Women Having a Breast Tumor Biopsy

Speaker Credentials

OMS-IV

College

Dr. Kiran C. Patel College of Osteopathic Medicine, DO

Location

Nova Southeastern University, Davie, Florida, USA

Format

Poster

Start Date

21-2-2020 8:30 AM

End Date

21-2-2020 4:00 PM

Abstract

Objective. Determine TDC values of female breasts and effects of benign vs. malignant tumors. Background. TDC values can assess breast-cancer-treatment-related lymphedema. However, little is known about how breast TDC values are impacted by tumor-type (benign vs. malignant). Methods. Women (N=38) scheduled for a breast biopsy participated. Prior to biopsy, TDC was measured at; a standard-site bilaterally, over the tumor-site and at a similar healthy-breast site. Standard-site was adjacent and superior to the areola. TDC was measured with a probe that touched a breast for 5-seconds. Malignant-tumor patients (14) were older with larger tumors. Results: Standard-siteTDC values of biopsied vs. healthy-breasts (mean ± SD) were similar (30.9±4.3 vs. 30.5±4.7, N=38, p=0.317) and overall equal to 30.7±4.5. Tumor- carrying breast tumor-site values were greater than for healthy-breasts (31.9±6.7 vs. 30.3±6.5, N=38, p=0.009). Malignant-tumor TDC values (N=14) were greater than for healthy-breasts (32.6±6.2 vs. 29.0±5.9, p=0.008). Breasts with benign-tumors (N=24), showed no difference in TDC values between tumor vs. other breast (31.5±7.0 vs. 31.2±6.7, p=0.280). TDC at malignant-tumors was higher than standard-sites, but not statistically different (32.6±6.2 vs. 30.4±3.3, p=0.173.) Corresponding values on benign-tumor breasts were 31.5±7.0 vs. 31.2±4.8, p= 0.843). Conclusion: Results provide reference TDC values for standardized breast sites useful as comparison values for future studies about breast edema due to breast-cancer-treatment. Additionally, results show slightly greater TDC values at malignant-tumor sites vs. the contralateral healthy-breast site. However, it is not clear as yet if this difference is sufficient to provide useful diagnostic sensitivity of tumor type.

This document is currently not available here.

Share

COinS
 
Feb 21st, 8:30 AM Feb 21st, 4:00 PM

Breast Tissue Dielectric Constant (TDC) Assessed in Women Having a Breast Tumor Biopsy

Nova Southeastern University, Davie, Florida, USA

Objective. Determine TDC values of female breasts and effects of benign vs. malignant tumors. Background. TDC values can assess breast-cancer-treatment-related lymphedema. However, little is known about how breast TDC values are impacted by tumor-type (benign vs. malignant). Methods. Women (N=38) scheduled for a breast biopsy participated. Prior to biopsy, TDC was measured at; a standard-site bilaterally, over the tumor-site and at a similar healthy-breast site. Standard-site was adjacent and superior to the areola. TDC was measured with a probe that touched a breast for 5-seconds. Malignant-tumor patients (14) were older with larger tumors. Results: Standard-siteTDC values of biopsied vs. healthy-breasts (mean ± SD) were similar (30.9±4.3 vs. 30.5±4.7, N=38, p=0.317) and overall equal to 30.7±4.5. Tumor- carrying breast tumor-site values were greater than for healthy-breasts (31.9±6.7 vs. 30.3±6.5, N=38, p=0.009). Malignant-tumor TDC values (N=14) were greater than for healthy-breasts (32.6±6.2 vs. 29.0±5.9, p=0.008). Breasts with benign-tumors (N=24), showed no difference in TDC values between tumor vs. other breast (31.5±7.0 vs. 31.2±6.7, p=0.280). TDC at malignant-tumors was higher than standard-sites, but not statistically different (32.6±6.2 vs. 30.4±3.3, p=0.173.) Corresponding values on benign-tumor breasts were 31.5±7.0 vs. 31.2±4.8, p= 0.843). Conclusion: Results provide reference TDC values for standardized breast sites useful as comparison values for future studies about breast edema due to breast-cancer-treatment. Additionally, results show slightly greater TDC values at malignant-tumor sites vs. the contralateral healthy-breast site. However, it is not clear as yet if this difference is sufficient to provide useful diagnostic sensitivity of tumor type.